BioCatalystWatch
ATOSWorkspace / ATOS / OverviewCompany library
ATOSSA THERAPEUTICS, INC. logo

ATOSSA THERAPEUTICS, INC.

ATOSSA THERAPEUTICS, INC. (ATOS)

Website

Price
Market cap
Next catalystKARISMA follow-up results at SABCS in December 2026oral (Z)-endoxifen — KARISMA · Data readoutCompany source ↗
Cash

Chart & Events

Candle interval

Core Clinical

oral (Z)-endoxifen

ERα × PKCβ1

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

oral (Z)-endoxifen

ERα × PKCβ1

PreINDP1P2P3FilingApproved

oral (Z)-endoxifen

ERα × PKCβ1

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

oral (Z)-endoxifen

ERα × PKCβ1

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

oral (Z)-endoxifen

ERα × PKCβ1

PreINDP1P2P3FilingApproved
Upcoming / outlook

oral (Z)-endoxifen

ERα × PKCβ1

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

oral (Z)-endoxifen

ERα × PKCβ1

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Technology Summary

Scientific context

Detailed technology interpretation

Technology advantages

Representative pipeline applications

Disease and market context

Detailed science focus

Background, answer, next evidence

Clinical

Upcoming clinical milestones

oral (Z)-endoxifen

ERα × PKCβ1

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

oral (Z)-endoxifen

ERα × PKCβ1

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

oral (Z)-endoxifen

ERα × PKCβ1

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

  • Timing and evidence

oral (Z)-endoxifen

ERα × PKCβ1

PreINDP1P2P3FilingApproved
Upcoming / outlook

oral (Z)-endoxifen

ERα × PKCβ1

PreINDP1P3FilingApproved
Upcoming / outlook

  • Timing and evidence

oral (Z)-endoxifen

ERα × PKCβ1

PreINDP1P2P3FilingApproved
Upcoming / outlook

  • Timing and evidence

Other pipelines

oral (Z)-endoxifen

ERα × PKCβ1

PreINDP1P2P3FilingApproved

History / paused

PreINDP1P2P3FilingApproved

Financial position

Short-term investments

Net operating cash flow

Source and basis

Company funding outlook

Upcoming milestones

Financial history

Amounts and sources
PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing



PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing




PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

PeriodCashCurrent investmentsOperatingInvestingFinancing

Source

Annual trends

Reported item

Reported shares and borrowings

Source and basis

Source and basis

Ownership and institutions

Status

Market Reaction / Supply Context

Market Structure

ATOS PR & News

PR & News

ATOS SEC archive